SCHEMBL29520489

SCHEMBL29520489

CC1(C)OB(c2nc3ccccc3n2COCC[Si](C)(C)C)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.38
HSD17B10 Q99714 3/20 0.38
NPC1 O15118 4/20 0.38
TP53 P04637 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 2/20 0.36
HPGD P15428 2/20 0.36
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065409 0.79 POLB (0.44) KDM4EHSD17B10NPC1ALDH1A1SMN1; SMN2
SCHEMBL17969377 0.78 KDM4E (0.35) KDM4EHSD17B10NPC1TP53RAB9A
SCHEMBL29520372 0.76 NPC1 (0.42) KDM4EHSD17B10NPC1TP53RAB9A
SCHEMBL6259455 0.76 NPC1 (0.42) KDM4EHSD17B10NPC1TP53RAB9A
SCHEMBL30638944 0.76 HTT (0.56) KDM4ENPC1TP53ALDH1A1HPGD
SCHEMBL1192213 0.76 LMNA (0.47) KDM4EHSD17B10NPC1TP53RAB9A
SCHEMBL5252051 0.76 NPC1 (0.42) KDM4EHSD17B10NPC1TP53RAB9A
SCHEMBL22095110 0.75 TSHR (0.51) KDM4ENPC1TP53RAB9AALDH1A1
SCHEMBL18543756 0.74 NPC1 (0.38) KDM4EHSD17B10NPC1ALDH1A1SMN1; SMN2
SCHEMBL25346913 0.74 IRAK4 (0.36) KDM4ENPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063140-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AS HPK1 MODULATOR AND METHODS USING SAME SHENZHEN IONOVA LIFE SCIENCE CO., LTD. (CN) 2022-03-31 WO disclosed